Previous studies have demonstrated that DDX3X facilitated EBV infection and promoted EBV-related gene expression in EBV+ NK cells by modulating the RLR pathway, thereby playing a pivotal role in the development and progression of EBV-T/NK-LPDs [5]. The gene discussed is DDX3X; the disease is Epstein-Barr virus infection.